D
Nurix Therapeutics, Inc. NRIX
$13.59 $0.403.03%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Revenue 54.55M 56.42M 62.30M 80.89M 76.99M
Total Other Revenue -- -- -- -- --
Total Revenue 54.55M 56.42M 62.30M 80.89M 76.99M
Cost of Revenue 221.63M 204.12M 196.50M 193.34M 189.15M
Gross Profit -167.08M -147.70M -134.19M -112.45M -112.16M
SG&A Expenses 45.94M 46.01M 44.91M 44.88M 42.90M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 267.58M 250.13M 241.41M 238.22M 232.05M
Operating Income -213.03M -193.70M -179.11M -157.33M -155.06M
Income Before Tax -193.30M -176.71M -164.82M -144.64M -143.95M
Income Tax Expenses 270.00K 262.00K 180.00K 90.00K --
Earnings from Continuing Operations -193.57 -176.98 -165.00 -144.73 -143.95
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -193.57M -176.98M -165.00M -144.73M -143.95M
EBIT -213.03M -193.70M -179.11M -157.33M -155.06M
EBITDA -205.01M -186.40M -172.25M -150.90M -148.93M
EPS Basic -2.89 -2.91 -2.92 -2.65 -2.65
Normalized Basic EPS -1.80 -1.82 -1.82 -1.66 -1.66
EPS Diluted -2.89 -2.91 -2.92 -2.65 -2.65
Normalized Diluted EPS -1.80 -1.82 -1.82 -1.66 -1.66
Average Basic Shares Outstanding 268.47M 244.73M 226.34M 218.22M 217.35M
Average Diluted Shares Outstanding 268.47M 244.73M 226.34M 218.22M 217.35M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings